comparemela.com

Latest Breaking News On - மேலும் வரவிருக்கும் அறிக்கைகள் - Page 5 : comparemela.com

Developers of Robotic Technologies Lean on Safety and Accuracy to Boost Patient Outcomes in Surgical Robots Market, Global Valuation to Touch ~US$ 13 1 Bn by 2022: TMR

Developers of Robotic Technologies Lean on Safety and Accuracy to Boost Patient Outcomes in Surgical Robots Market, Global Valuation to Touch ~US$ 13 1 Bn by 2022: TMR
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Players Aim at Offering Economical Solutions in Medical Nonwoven Disposables Market, Green Wipes to Unlock New Consumer Propositions: TMR

Players Aim at Offering Economical Solutions in Medical Nonwoven Disposables Market, Green Wipes to Unlock New Consumer Propositions: TMR
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Increased Number of Patients with Hereditary Antithrombin Deficiency Boosts Sales in Antithrombin Market: TMR

Testing for Latent Infection in Tuberculosis Testing Market Spurs Best Control Practices, Valuation to Rise at CAGR of 4 0% from 2019 to 2027: TMR

Share this article Share this article ALBANY, N.Y., June 9, 2021 /PRNewswire/ Tuberculosis testing has advanced continuously over the years to help in the diagnosis of TB and occupies a key role in preventing its transmission. Adoption of infection control practices has propelled healthcare providers in collaboration with government to identify at-risk populations. The high mortality of pulmonary tuberculosis has led to remarkable advancements in culture-based tests. Tests to identify Mycobacterium tuberculosis in the body, a gold standard for testing, has been extensively helpful in reducing the burden of active tuberculosis. Advances in such tests are expanding the avenue in the tuberculosis testing market. However, Mantoux TST needs a follow-up tests, and has shown limited success in confirming TB disease in the individual. The lack of TST antigen is a key factor for its limited efficacy in developing world.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.